Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients

Carcinogenesis

Volumn 34, Issue 12, 2013, Pages 2767-2773

  Galvan, Antonella ^a   Frullanti, Elisa ^a,g   Anderlini, Marco ^a   Manenti, Giacomo ^a   Noci, Sara ^a   Dugo, Matteo ^a   Ambrogi, Federico ^b   De Cecco, Loris ^a   Spinelli, Roberta ^c   Piazza, Rocco ^c   Pirola, Alessandra ^c   Gambacorti Passerini, Carlo ^c,d   Incarbone, Matteo ^e,f   Alloisio, Marco ^e   Tosi, Davide ^b   Nosotti, Mario ^b   Santambrogio, Luigi ^b   Pastorino, Ugo ^a   Dragani, Tommaso A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^f IRCCS MULTIMEDICA   (Italy)

^g UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CNTNAP1 GENE; CONTROLLED STUDY; FAM156A GENE; FEMALE; FRMD8 GENE; GALNTL1 GENE; GENE; GENE EXPRESSION PROFILING; GENE FUSION; GENETIC TRAIT; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PKNOX1 GENE; PPP3RI GENE; PRIORITY JOURNAL; RNA SEQUENCE; SERPINH1 GENE; SNTB1 GENE; SNX10 GENE; TUMOR MICROENVIRONMENT; TXNDC12 GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84889067778     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt294     Document Type: Article

References (39)

1. Goldstraw,P. et al. (2011) Non-small-cell lung cancer. Lancet, 378, 1727-1740.
2. Marin,J.J. et al. (2012) Genetic variants in genes involved in mechanisms of chemoresistance to anticancer drugs. Curr. Cancer Drug Targets, 12, 402-438.
3. Cadranel,J. et al. (2012) Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project-part 2). J. Thorac. Oncol., 7, 1490-1502.
4. Johnson,M.L. et al. (2013) Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas. Cancer, 119, 356-362.
5. Huang,Y.T. et al. (2009) Genome-wide analysis of survival in early-stage non-small-cell lung cancer. J. Clin. Oncol., 27, 2660-2667.
6. Lee,Y. et al. (2013) Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study. Carcinogenesis, 34, 307-313.
7. Franke,L. et al. (2009) eQTL analysis in humans. Methods Mol. Biol., 573, 311-328.
8. Kadara,H. et al. (2012) Pulmonary adenocarcinoma: a renewed entity in 2011. Respirology, 17, 50-65.
9. Seo,J.S. et al. (2012) The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res., 22, 2109-2119.
10. Park,Y.Y. et al. (2012) Development and validation of a prognostic geneexpression signature for lung adenocarcinoma. PLoS One, 7, e44225.
11. Frullanti,E. et al. (2011) Multiple genetic loci modulate lung adenocarcinoma clinical staging. Clin. Cancer Res., 17, 2410-2416.
12. Frullanti,E. et al. (2012) Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue. Int. J. Cancer, 131, E643-648.
13. Dassano,A. et al. (2013) Multigenic nature of the mouse pulmonary adenoma progression 1 locus. BMC Genomics, 14, 152.
14. Spira,A. et al. (2004) Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc. Natl Acad. Sci. USA, 101, 10143-10148.
15. Du,P. et al. (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics, 24, 1547-1548.
16. Gentleman,R.C. et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol., 5, R80.
17. Trapnell,C. et al. (2009) TopHat: discovering splice junctions with RNASeq. Bioinformatics, 25, 1105-1111.
18. Robinson,J.T. et al. (2011) Integrative genomics viewer. Nat. Biotechnol., 29, 24-26.
19. Zeggini,E. et al.; Wellcome Trust Case Control Consortium. (2008) Metaanalysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet., 40, 638-645.
20. Normand,S.L. (1999) Meta-analysis: formulating, evaluating, combining, and reporting. Stat. Med., 18, 321-359.
21. Kadara,H. et al. (2012) Field cancerization in non-small cell lung cancer: implications in disease pathogenesis. Proc. Am. Thorac. Soc., 9, 38-42.
22. Goldie,S.J. et al. (2012) FRMD4A upregulation in human squamous cell carcinoma promotes tumor growth and metastasis and is associated with poor prognosis. Cancer Res., 72, 3424-3436.
23. Wang,T. et al. (2012) FERM-containing protein FRMD5 is a p120-catenin interacting protein that regulates tumor progression. FEBS Lett., 586, 3044-3050.
24. Wu,Y.M. et al. (2011) Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor. Cancer Res., 71, 7270-7279.
25. Longobardi,E. et al. (2010) Prep1 (pKnox1)-deficiency leads to spontaneous tumor development in mice and accelerates EmuMyc lymphomagenesis: a tumor suppressor role for Prep1. Mol. Oncol., 4, 126-134.
26. Iotti,G. et al. (2011) Homeodomain transcription factor and tumor suppressor Prep1 is required to maintain genomic stability. Proc. Natl Acad. Sci. USA, 108, E314-E322.
27. Schaeffer,P.J. et al. (2009) Impaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice. Am. J. Physiol. Heart Circ. Physiol., 297, H1263-H1273.
28. Goodyer,W.R. et al. (2012) Neonatal ß cell development in mice and humans is regulated by calcineurin/NFAT. Dev. Cell, 23, 21-34.
29. Ishida,Y. et al. (2011) Hsp47 as a collagen-specific molecular chaperone. Methods Enzymol., 499, 167-182.
30. Kakugawa,T. et al. (2013) Serum heat shock protein 47 levels are elevated in acute exacerbation of idiopathic pulmonary fibrosis. Cell Stress Chaperones, 18, 581-590.
31. Johnson,E.K. et al. (2012) Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins. PLoS One, 7, e43515.
32. Zhu,C.H. et al. (2012) SNX10 is required for osteoclast formation and resorption activity. J. Cell. Biochem., 113, 1608-1615.
33. Pangrazio,A. et al. (2013) SNX10 mutations define a subgroup of human autosomal recessive osteopetrosis with variable clinical severity. J. Bone Miner. Res., 28, 1041-1049.
34. Vincent,E.E. et al. (2011) Overexpression of the TXNDC5 protein in nonsmall cell lung carcinoma. Anticancer Res., 31, 1577-1582.
35. Lu,A. et al. (2012) TXNDC9 expression in colorectal cancer cells and its influence on colorectal cancer prognosis. Cancer Invest., 30, 721-726.
36. Beer,D.G. et al. (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med., 8, 816-824.
37. Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, et al. (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat. Med., 14, 822-827.
38. Tomida,S. et al. (2009) Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. J. Clin. Oncol., 27, 2793-2799.
39. Lu,Y. et al. (2012) Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients. PLoS One, 7, e30880.